Inhibitors of acyl CoA: cholesterol acyltransferase
…, R Burrier, J Clader, H Davis, M Domalski…
Index: Vaccaro, Wayne; Amore, Cindy; Berger, Joel; Burrier, Robert; Clader, John; Davis, Harry; Domalski, Martin; Fevig, Tom; Salisbury, Brian; Sher, Rosy Journal of Medicinal Chemistry, 1996 , vol. 39, # 8 p. 1704 - 1719
Full Text: HTML
Citation Number: 49
Abstract
Conformational restriction of previously disclosed acyclic diphenylethyl) diphenylacetamides led to the discovery of several potent inhibitors of acyl CoA: cholesterol acyltransferase (ACAT). cis-[2-(4-Hydroxyphenyl)-1-indanyl] diphenylacetamide (4a) was the most potent ACAT inhibitor identified (IC50= 0.04 μM in an in vitro rat hepatic microsomal ACAT assay, ED50= 0.72 mg/kg/day in cholesterol-fed hamsters).
Related Articles:
Palladium-catalyzed regiocontrolled α-arylation of trimethylsilyl enol ethers with aryl halides
[Iwama, Tetsuo; Rawal, Viresh H. Organic Letters, 2006 , vol. 8, # 25 p. 5725 - 5728]
Palladium-catalyzed regiocontrolled α-arylation of trimethylsilyl enol ethers with aryl halides
[Iwama, Tetsuo; Rawal, Viresh H. Organic Letters, 2006 , vol. 8, # 25 p. 5725 - 5728]
[Lee, Kilsung; Oh, Dong Young Tetrahedron Letters, 1988 , vol. 29, # 24 p. 2977 - 2978]
Discovery of N-(2-aryl-cyclohexyl) substituted spiropiperidines as a novel class of GlyT1 inhibitors
[Pinard, Emmanuel; Ceccarelli, Simona M.; Stalder, Henri; Alberati, Daniela Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 2 p. 349 - 353]